Meei-Li Huang, PhD

Research Scientist
University of Washington

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1149 - Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 2094 - A prospective multicenter study of HHV-6B genomic DNA and gene transcription in paired bronchoalveolar lavage fluid and blood from HCT recipients
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2109 - HHV-6 and EBV Reactivation after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis: A Retrospective Cohort Study
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET